Physician

Robert Benjamin Ash, MD

According to 2025 Medicare claims, Robert Ash, MD (NPI: 1720073885) practices dermatology in the Dothan, AL market, with the plurality of this provider's patient population coming from Houston, AL. This provider's primary affiliated billing organization is AFFILIATED DERMATOLOGY, PC (NPI: 1124008636; TIN: 63-1025971) and primary practice location at 36305-1306.

Ash's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,217 traditional Medicare patients, billed 9,053 HCPCS/CPT codes, and received $441,915 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 1,152 prescription claims across 522 beneficiaries totaling $182,042 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 46 records totaling $1,249. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $640,051 to $441,915. In contrast, Part D prescription costs have risen steadily, from $118,465 to $182,042. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$320K$640K2015 Medicare payment: $640,051 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $635,911 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $486,228 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $473,031 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $485,190 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $458,128 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $481,276 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $360,131 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $379,923 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $441,915 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,35815,839$640,051
20162,28016,221$635,911
20171,84512,730$486,228
20181,68912,025$473,031
20191,67411,576$485,190
20201,47010,348$458,128
20211,37210,126$481,276
20221,2248,018$360,131
20231,2348,562$379,923
20241,2179,053$441,915

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$105K$209K2015 Drug cost: $118,465 (USD; Tot_Drug_Cst)2016 Drug cost: $107,619 (USD; Tot_Drug_Cst)2017 Drug cost: $72,396 (USD; Tot_Drug_Cst)2018 Drug cost: $70,330 (USD; Tot_Drug_Cst)2019 Drug cost: $137,219 (USD; Tot_Drug_Cst)2020 Drug cost: $91,710 (USD; Tot_Drug_Cst)2021 Drug cost: $135,185 (USD; Tot_Drug_Cst)2022 Drug cost: $155,581 (USD; Tot_Drug_Cst)2023 Drug cost: $209,434 (USD; Tot_Drug_Cst)2024 Drug cost: $182,042 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015290691$118,465
2016295691$107,619
2017297654$72,396
2018263612$70,330
2019332745$137,219
2020350760$91,710
2021414956$135,185
2022389883$155,581
2023414933$209,434
20245221,152$182,042

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths209314$103
11102Biopsy of related skin growth, first growth462648$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0151,327$57
17000Destruction of precancer skin growth, 1 growth8041,162$38
17003Destruction of precancer skin growth, 2-14 growths6384,019$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab12336$44,904
FluorouracilFluorouracil411,065$3,138
MetronidazoleMetronidazole371,084$2,596
Triamcinolone AcetonideTriamcinolone Acetonide2055,444$2,209
MupirocinMupirocin2484,804$1,904

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.46$1,249Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Robert Benjamin Ash, MD?

Tedicare shows public-source Medicare data for Robert Benjamin Ash, MD (NPI 1720073885), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Benjamin Ash, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Benjamin Ash, MD?

Robert Benjamin Ash, MD is linked to AFFILIATED DERMATOLOGY, PC (billing NPI 1124008636) in the available physician profile data.

Does Robert Benjamin Ash, MD have Open Payments data?

Robert Benjamin Ash, MD has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.